Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients

Haematologica

Volumn 89, Issue 11, 2004, Pages 1332-1340

  Zadra, Giorgia ^a   Asselta, Rosanna ^a   Malcovati, Massimo ^a   Santagostino, Elena ^a   Peyvandi, Flora ^a   Mannucci, Pier Mannuccio ^a   Tenchini, Maria Luisa ^a   Duga, Stefano ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS Maggiore Hospital ^*  (Italy)

Author keywords

Deletion; FXI deficiency; Italian patients; Nonsense mutation; Type II mutation

Indexed keywords

BLOOD CLOTTING FACTOR 11;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL ARTICLE; CONGENITAL BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROPHORESIS; EXON; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; ITALY; JEW; MALE; NONHUMAN; NONSENSE MUTATION; PROTEIN SECRETION; RNA DEGRADATION;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; CODON, NONSENSE; COS CELLS; FACTOR XI DEFICIENCY; FEMALE; GENE DELETION; HAPLOTYPES; HUMANS; ITALY; JEWS; MALE; MIDDLE AGED;

EID: 9144223016     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Fujikawa K, Legaz ME, Kato H, Davie EW. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). Biochemistry 1974; 13:4508-16.
2. Davie EW, Fujikawa K, Kurachi K, Kisiel W. The role of serine proteases in the blood coagulation cascade. Adv Enzymol Relat Areas Mol Biol 1979;48:277-318.
3. Fujikawa K, Chung DW, Hendrickson LE, Davie EW. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 1986;25:2417-24.
4. Hsu TS, Shore S, Seshsmma T, Bagasra O, Walsh PN. Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene. J Biol Chem 1998; 273:13787-93.
5. Thompson RE, Mandle R, Kaplan AP. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest 1977;60:1376-80.
6. Bouma BN, Griffin JH. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. J Biol Chem 1977; 252:6432-7.
7. Mc Mullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. Biochemistry 1991; 30:2056-60.
8. UCSC Genome Browser. Available at URL: http://genome.ucsc.edu/
9. Asakai R, Davie EW, Chung DW. Organization of the gene for human factor XI. Biochemistry 1987;26:7221.
10. Rosenthal RL, Dreskin OH, Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 1953; 82:171-4.
11. Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor IX coagulant activity, and factor XI- antigen in 25 factor IX-deficient kindreds. Blood 1985; 65:719-24.
12. Shirk RA, Konkle BA, Walsh PN. Nonsense mutation in exon V of the factor XI gene does not abolish platelet factor XI expression. Br J Haematol 2000; 111:91-5.
13. Peyvandi F, Lak M, Mannucci PM. Factor XI deficiency in Iranians: its clinical manifestations in comparison with those of classic hemophilia. Haematologica 2002; 87:512-4.
14. Kravtsov DV, Wu W, Meijers J, Sun MF, Blinder MA, Dang TP, et al. Dominant Factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood 2004; 104:128-34.
15. Seligsohn U. High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood 1978;51:1223-8.
16. Shpilberg O, Peretz H, Zivelin A, Yatuv R, Chetrit A, Kulka T, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995; 85:429-32.
17. Asakai R, Chung DW, Ratnoff OD, Davie EW. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci USA 1989;86:7667-71.
18. Hancock JF, Wieland K, Pugh RE, Martinowitz U, Schulman S, Kakkar W, et al. A molecular genetic study of factor XI gene. Blood 1991;77:1942-8.
19. Meijers J, Davie E, Chung D. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood 1992;79:1435-40.
20. Peretz H, Zivelin A, Usher S, Seligsohn U. A 14-bp deletion (codon 554 del AAG-gtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency. Hum Mutat 1996;8:77-8.
21. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991;325:153-8.
22. Zivelin A, Bauduer F, Ducout L, Peretz H, Rosenberg N, Yatuv R, et al. Factor XI deficiency in French Basques is caused pre-dominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 2002;99:2448-54.
23. Quelin F, Trossaert M, Sigaud M, Mazancourt PD, Fressinaud E. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. J Thromb Haemost 2004;2:71-6.
24. Bolton-Maggs PH, Peretz H, Butler R, Mountford R, Keeney S, Zacharski L, et al. A common ancestral mutation (C128X) occuring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2004;2:918-24.
25. Imanaka Y, Lal K, Nishimura T, Bolton-Maggs PH, Tuddenham EG, Mc Vey JH. Identification of two novel mutations in non-Jewish factor XI deficiency. Br J Haematol 1995;90:916-20.
26. Pugh RE, Mc Vey JH, Tuddenham EG, Hancock JF. Six point mutations that cause factor XI deficiency. Blood 1995; 85:1509-16.
27. Wistinghausen B, Reischer A, Oddoux C, Ostrer H, Nardi M, Karpatkin M. Severe factor XI deficiency in an Arab family associated with a novel mutation in exon 11. Br J Haematol 1997;99:575-7.
28. Martincic D, Zimmerman SA, Ware RE, Sun MF, Whitlock JA, Gailani D. Identification of mutations and polymorphisms in the factor XI genes of an African-American family dideoxyfingerprinting. Blood 1998; 92:3309-17.
29. Alhaq A, Mitchell M, Sethi M, Rahman S, Flynn G, Boulton P, et al. Identification of a novel mutation in a non-Jewish factor XI deficient kindred. Br J Haematol 1999;104:44-9.
30. Mitchell M, Cutler J, Thompson S, Moore G, Jenkins Ap Rees E, Smith M, et al. Heterozygous factor XI deficiency associated with three novel mutations. Br J Haematol 1999;107:763-5.
31. Iijima K, Udagawa A, Kawasaki H, Murakami F, Shimomura T, Ikawa S. A factor XI deficiency associated with a nonsense mutation (Trp501stop) in the catalytic domain. Br J Haematol 2000; 111:556-8.
32. Sato E, Kawamata N, Kato A, Oshimi K. A novel mutation that leads to a congenital factor XI deficiency in a Japanese family. Am J Haematol 2000;63:165-9.
33. Ventura C, Santos AI, Tavares A, Gago T, Lavinha J, McVey JH, et al. Molecular genetic analysis of factor XI deficiency: identification of five novel gene alterations and the origin of type II mutation in Portuguese families. Thromb Haemost 2000; 84:833-40.
34. Dossenbach-Glaninger A, Krugluger W, Schrattbauer K, Eder S, Hopmeier P. Severe factor XI deficiency caused by a compound heterozygosity for the type III mutation and a novel insertion in exon 9 (codon 324/325+G). Br J Haematol 2001;114: 875-7.
35. Mitchell M, Harrington P, Cutler J, Rangarajan S, Savidge G, Alhaq A.. Eighteen unrelated patients with factor XI deficiency, four novel mutations and a 100% detection rate by denaturing high-performance liquid chromatography. Br J Haematol 2003;121:500-2.
36. Wu WM, Wang HL, Wang XF, Chu HY, Fu QH, Ding QL, et al. Identification of two novel factor XI non-sense mutation Trp228stop and Trp383stop in a Chinese pedigree of congenital factor XI deficiency. Zhonghua Xue Ye Xue Za Zhi 2003;24:126-8.
37. Tsukahara A, Yamada T, Takagi A, Murate T, Matsushita T, Saito H, et al. Compound heterozygosity for two novel mutations in a severe factor XI deficiency. Am J Hematol 2003;73:279-84.
38. Au WY, Cheung JW, Lam CC, Kwong YL. Two factor XI mutations in a Chinese family with factor XI deficiency. Am J Hematol 2003;74:136-8.
39. de Moerloose P, Germanos-Haddad M, Boehlen F, Neerman-Arbez M. Severe factor XI deficiency in a Lebanese family: identification of a novel missense mutation (Trp501Cys) in the catalytic domain. Blood Coagul Fibrinolysis 2004; 15:269-72.
40. Wu WM, Ding QL, Wang XF, Fu QH, Wang WB, Dai J, et al. FXI gene mutations in two pedigrees of congenital clotting factor XI deficiency Zhonghua Xue Ye Xue Za Zhi 2004;25:132-5.
41. Dai L, Mitchell M, Carson P, Creagh D, Cutler J, Savidge G, et al. Severe factor XI deficiency caused by compound heterozygosity. Br J Haematol 2004; 125:817-8.
42. Gerdes VE, Kraaijenhagen RA, Vogels EW, ten Cate H, Reitsma PH. Factor XI gene analysis in thrombophilia and factor XI deficiency. J Thromb Haemost 2004; 2:1015-7.
43. Mitchell MJ, Dai L, Savidge GF, Alhaq A. An Alu-mediated 31.5 kb deletion as the cause of factor XI deficiency in two unrelated patients. Blood 2004;104:2394-6.
44. Butler MG, Parsons AD. RFLPfor intron E of factor XI gene. Nucleic Acids Res 1990; 18:5327.
45. Bodfish P, Warne D, Watkins C, Nyberg K, Spurr NK. Dinucleotide repeat polymorphism in the human coagulation factor XI gene, intron B (F11), detected using the polymerase chain reaction. Nucleic Acids Res 1991;19:6979.
46. Peretz H, Mulai A, Usher S, Zivelin A, Segal A, Weisman Z, et al. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. Blood 1997;90:2654-9.
47. Duga S, Asselta R, Santagostino E, Zeinali S, Simonic T, Malcovati M, et al. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood 2000; 95:1336-41.
48. Sun Y, Gailani D. Identification of a factor IX binding site on the third apple domain of activated factor XI. J Biol Chem 1996; 271:29023-8.
49. Zhang JX, Braakman I, Matlack KES, Helenius A. Quality control in the secretory pathway: the role of calreticulin, calnexin and Bip in the retention of glycoproteins with C-terminal truncations. Mol Biol Cell 1997;8:1943-54.
50. Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Gen 1999;8:1893-900.
51. Emmerich J, Chadeuf G, Alhenc-Gelas M, Gouault-Heilman M, Toulon P, Fiessinger JN, et al. Molecular basis of antithrombin type I deficiency: the first large in-frame deletion and two novel mutations in exon 6. Thromb Haemost 1994;72:534-9.
52. th Congress of the International Society of Hematology, London, 1992. p. 131.